西沙必利与患者信息手册。 - Suppr

Suppr

超能文献

Cisapride and patient information leaflets.

作者信息

Sukkari S R, Sasich L D

出版信息

CMAJ. 2001 May 1;164(9):1276-8; author reply 1278-9.

PMID:11341134

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC81006/

Abstract

摘要

相似文献

Cisapride and patient information leaflets.

CMAJ. 2001 May 1;164(9):1276-8; author reply 1278-9.

Lessons from cisapride.

CMAJ. 2001 May 1;164(9):1269, 1271.

Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions.

Am J Gastroenterol. 2001 Jun;96(6):1698-703. doi: 10.1111/j.1572-0241.2001.03927.x.

Cisapride class-action suit approved.

CMAJ. 2007 Feb 27;176(5):615. doi: 10.1503/cmaj.070156.

The impact of wording in "Dear doctor" letters and in black box labels.

Clin Pharmacol Ther. 2002 Dec;72(6):735-42. doi: 10.1067/mcp.2002.129503.

Cisapride: the problem of the heart.

Neonatal Netw. 1999 Oct;18(7):21-5. doi: 10.1891/0730-0832.18.7.21.

Cisapride fallout? Canada to gain access to largest adverse-event database.

CMAJ. 2002 Oct 1;167(7):790.

Prolongation of the QT interval and cardiac arrhythmias associated with cisapride: limitations of the pharmacoepidemiological studies conducted and proposals for the future.

Pharmacoepidemiol Drug Saf. 2003 Jan-Feb;12(1):31-40. doi: 10.1002/pds.781.

Red sky in the morning: modifying prescription drug labels as a result of postmarket surveillance.

Food Drug Law J. 2007;62(3):529-46.

Update from the Canadian Dyspepsia Working Group.

CMAJ. 2000 Sep 19;163(6):696.

引用本文的文献

Written information about individual medicines for consumers.

Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD002104. doi: 10.1002/14651858.CD002104.pub3.

Incomplete patient drug information still a problem.

CMAJ. 2004 Nov 9;171(10):1149-50; author reply 1150. doi: 10.1503/cmaj.1040296.

Lessons from cisapride.

CMAJ. 2001 May 1;164(9):1269, 1271.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cisapride and patient information leaflets.

作者信息

Sukkari S R, Sasich L D

出版信息

CMAJ. 2001 May 1;164(9):1276-8; author reply 1278-9.

PMID:11341134

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC81006/

Abstract

摘要

相似文献

Cisapride and patient information leaflets.

CMAJ. 2001 May 1;164(9):1276-8; author reply 1278-9.

Lessons from cisapride.

CMAJ. 2001 May 1;164(9):1269, 1271.

Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions.

Am J Gastroenterol. 2001 Jun;96(6):1698-703. doi: 10.1111/j.1572-0241.2001.03927.x.

Cisapride class-action suit approved.

CMAJ. 2007 Feb 27;176(5):615. doi: 10.1503/cmaj.070156.

The impact of wording in "Dear doctor" letters and in black box labels.

Clin Pharmacol Ther. 2002 Dec;72(6):735-42. doi: 10.1067/mcp.2002.129503.

Cisapride: the problem of the heart.

Neonatal Netw. 1999 Oct;18(7):21-5. doi: 10.1891/0730-0832.18.7.21.

Cisapride fallout? Canada to gain access to largest adverse-event database.

CMAJ. 2002 Oct 1;167(7):790.

Prolongation of the QT interval and cardiac arrhythmias associated with cisapride: limitations of the pharmacoepidemiological studies conducted and proposals for the future.

Pharmacoepidemiol Drug Saf. 2003 Jan-Feb;12(1):31-40. doi: 10.1002/pds.781.

Red sky in the morning: modifying prescription drug labels as a result of postmarket surveillance.

Food Drug Law J. 2007;62(3):529-46.

Update from the Canadian Dyspepsia Working Group.

CMAJ. 2000 Sep 19;163(6):696.

引用本文的文献

Written information about individual medicines for consumers.

Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD002104. doi: 10.1002/14651858.CD002104.pub3.

Incomplete patient drug information still a problem.

CMAJ. 2004 Nov 9;171(10):1149-50; author reply 1150. doi: 10.1503/cmaj.1040296.

Lessons from cisapride.

CMAJ. 2001 May 1;164(9):1269, 1271.